![Frontiers | Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium–Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects Frontiers | Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium–Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects](https://www.frontiersin.org/files/Articles/507379/fphar-11-01033-HTML/image_m/fphar-11-01033-g001.jpg)
Frontiers | Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium–Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects
Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders | PLOS ONE
![Frontiers | Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis Frontiers | Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis](https://www.frontiersin.org/files/Articles/370908/fpsyt-09-00187-HTML/image_m/fpsyt-09-00187-g002.jpg)
Frontiers | Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis
![A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity | eLife A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity | eLife](https://iiif.elifesciences.org/lax/50036%2Felife-50036-fig9-v2.tif/full/1500,/0/default.jpg)
A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity | eLife
![TransDTI: Transformer-Based Language Models for Estimating DTIs and Building a Drug Recommendation Workflow | ACS Omega TransDTI: Transformer-Based Language Models for Estimating DTIs and Building a Drug Recommendation Workflow | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.1c05203/asset/images/large/ao1c05203_0008.jpeg)
TransDTI: Transformer-Based Language Models for Estimating DTIs and Building a Drug Recommendation Workflow | ACS Omega
![Population-scale identification of differential adverse events before and during a pandemic | Nature Computational Science Population-scale identification of differential adverse events before and during a pandemic | Nature Computational Science](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43588-021-00138-4/MediaObjects/43588_2021_138_Fig1_HTML.png)
Population-scale identification of differential adverse events before and during a pandemic | Nature Computational Science
![Guidelines for Temperature Control of Drug Products during Storage and Transportation (GUI-0069) - Canada.ca Guidelines for Temperature Control of Drug Products during Storage and Transportation (GUI-0069) - Canada.ca](https://www.canada.ca/content/dam/hc-sc/images/services/drug-and-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/GUI-0069_V3_EN_Aug%2010.png)
Guidelines for Temperature Control of Drug Products during Storage and Transportation (GUI-0069) - Canada.ca
SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy | PLOS Computational Biology
![Prescribers' reported acceptance and use of drug-drug interaction alerts: An Australian survey - Melissa T Baysari, Bethany A Van Dort, Wu Yi Zheng, Ling Li, Sarah Hilmer, Johanna Westbrook, Richard Day, 2022 Prescribers' reported acceptance and use of drug-drug interaction alerts: An Australian survey - Melissa T Baysari, Bethany A Van Dort, Wu Yi Zheng, Ling Li, Sarah Hilmer, Johanna Westbrook, Richard Day, 2022](https://journals.sagepub.com/cms/10.1177/14604582221100678/asset/images/large/10.1177_14604582221100678-fig1.jpeg)
Prescribers' reported acceptance and use of drug-drug interaction alerts: An Australian survey - Melissa T Baysari, Bethany A Van Dort, Wu Yi Zheng, Ling Li, Sarah Hilmer, Johanna Westbrook, Richard Day, 2022
![Dosing and Administration | NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension 100 U/mL Dosing and Administration | NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension 100 U/mL](https://www.novomedlink.com/diabetes/products/treatments/novologmix70-30/dosing-administration/_jcr_content/root/slab_976973855/content/container/container_926382279/image.img.png/1632651343717/titration-table.png)